World cardiovascular disease diagnostics market is primarily driven by development of enhanced diagnostics systems and procedures. Rising costs of materials and growing complexity of procedures characterize the field of cardiology today. Cardiovascular disease continues to remain the leading cause behind global mortality, resulting in tens of millions of deaths per annum. With the introduction of improved diagnostics, acute and chronic medications and surgical techniques, there has been a significant plunge in total cardiovascular disease mortality over the past few decades.

Worldwide cardiac diagnostic medical device market features intense competition triggered by rapid technology advancements and development initiatives. Increasing acceptance of Computed Tomography and Magnetic Resonance angiography is expected to modify cath-lab function. Today's cardiologists can contemplate the benefits of emerging 256-slice CT scanner technology. Imaging technologies are non-invasive and provide quicker diagnosis, which not only negates the requirement of invasive diagnostic techniques but also helps in early detection of the disease, especially in case of patients complaining undiagnosed acute chest pain.

These and other market data and trends are presented in "Cardiovascular Disease Diagnostics: A World Market Intelligence Report" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

1.Methodology
- Study Reliability and Reporting Limitations
- Disclaimers
- Quantitative Techniques & Reporting Level
2.Global Market Overview and Outlook
- Cardiology Diagnostic Imaging: Future Outlook
- Heart - Facts and Figures
- Swift Growth in Cardiovascular Disease Devices Market
- Cardiovascular Diseases Damaging Human Health
- Mounting Healthcare Costs- ""a Real Concern for Economies""
- Competition in The Cardiac Diagnostics Market
- Market Trends
- Advancement of Poc Testing Propels Cardiovascular Diagnostics Market
- Demand on Rise for Poc Cardiac Markers
- Minimal Invasive Procedure Hogs The Limelight of Cardiovascular Treatment
- Advancements in Alternate-Site Coagulation Monitoring
- Novel Imaging Techniques Boost in Vivo Diagnostic Market
- Strong Demand for Risk Assessment Markers
- New Technologies Bring Diagnostics Closer to Patients
- Trends Cited in The Imaging Technologies Market
- Ct Scanners
- Mri
- Move towards Efficient Patient Data Management
3.Product Facts
4.Corporate Developments
- Siemens Medical Acquires Dade Behring
- Inverness Medical Innovations Acquires Cholestech
- Acrongenomics, Pearson and Molecular Enter into Joint Venture
- Cholestech Teams up with Onsite Health Diagnostics
- Lipomics to Collaborate with Agilent Technologies to Develop Diagnostic Tests.
- Transgenomic and Fiuotecnica Renew Collaboration Agreement
- Alteon and Biorap Technologies Enter into An Agreement
- Im Medical Acquires New Technology for Detecting Cardiovascular Diseases
- Medtronic Establishes New Business Entity
- Siemens Medical Acquires Bayer Healthcare's Diagnostics Unit
- Philips Rolls out 256-Slice Ct Scanner, Brilliance Ict Scanner
- Royal Philips Launches Live 3D Transesophageal Echocardiogram Probe
- Ge Healthcare Launches Vivid E Ultrasound Systems
- Cardionetics Launches Ecg Monitor for 24-Hour Real-Time Cardiac Diagnosis
- Siemens Launches Imaging Release for The Acuson Sequoia Platform
- Ge Healthcare Launches Version 2.0 of Centricity Cardiology Ca1000
- Ge Healthcare Introduces New Capabilities to Cardiosoft Diagnostic Software
- Ge Healthcare's Lightspeed Vct Offers Imaging at 70% Lower Exposure
- Roche Diagnostics Launches Cobas H 232 Portable Cardiac Marker System (outside US)
- Royal Philips Launches New Imaging Tool for Complex Cardiac Arrhythmias
5.Major Players
- Abbott Diagnostics (USA)
- Biosite, Inc. (USA)
- Cambridge Heart, Inc. (USA)
- Cholestech Corp. (USA)
- Ep Medsystems (USA)
- Ge Healthcare (UK)
- Liposcience, Inc. (USA)
- Philips Healthcare (USA)
- Roche Diagnostics (Switzerland)
- Siemens Healthcare (Germany)
6.Global Market Analytics
7.The United States
- Cardio Vascular Disease (Cvd) - An Overview
- Startling Facts Related to Stroke in US
- Incidence of Coronary Heart Disease
- Mortality Rate of Chd
- Arrhythmias
- Cad Diagnostics
- Pvd Diagnostics
- Medicare Reimbursement Set for Cpt Code 83704
- Competitive Glance
- Point-of-Care (Poc) Diagnostic Market in The US
8.Canada
9.Japan
10.Europe
- A.France
- B.Germany
- C.Italy
- D.The United Kingdom
- E.Spain
- F.Russia
- G.Rest of Europe
11.Asia-Pacific
- Cardiovascular Market in Asia-Pacific
- China
- Cardiovascular Disease Patients Overview
- Chinese Cardiovascular Disease Treatment as A Part of Overall Health Care Industry
12. The Middle East
13.Latin America
Exhibits
- Table 1: Global Cardiovascular Disease Diagnostics Market by Region for The Period 2007-2015 (Sales in US$ Million)
- Table 2: Percentage Breakdown of Global Cardiovascular Disease Diagnostics Market by Region for The Years 2008 &
- Table 3: Global Cardiovascular in Vitro Diagnostics Market by Region for The Period 2007-2015 (Sales in US$ Million)
- Table 4: Percentage Breakdown of Global Cardiovascular in Vitro Diagnostics Market by Region for The Years 2008 &
- Table 5: Global Cardiovascular in Vivo Diagnostics Market by Region for The Period 2007-2015 (Sales in US$ Million)
- Table 6: Percentage Breakdown of Global Cardiovascular in Vivo Diagnostics Market by Region for The Years 2008 &
- Table 7: Percentage Breakdown of Leading Poc Cardiac Manufacturer Value Sales in The US -
- Table 8: Cardiovascular Disease Diagnostics Market by Product Segment in The US: 2007-2015 (Sales in US$ Million)
- Table 9: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in The US for The Years 2008 &
- Table 10: Cardiovascular Disease Diagnostics Market by Product Segment in Canada: 2007-2015 (Sales in US$ Million)
- Table 11: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Canada for The Years 2008 &
- Table 12: Cardiovascular Disease Diagnostics Market by Product Segment in Japan: 2007-2015 (Sales in US$ Million)
- Table 13: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Japan for The Years 2008 &
- Table 14: Cardiovascular Disease Diagnostics Market by Region in Europe: 2007-2015 (Sales in US$ Million)
- Table 15: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Region in Europe for The Years 2008 &
- Table 16: Cardiovascular Disease Diagnostics Market by Product Segment in Europe: 2007-2015 (Sales in US$ Million)
- Table 17: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Europe for The Years 2008 &
- Table 18: Cardiovascular Disease Diagnostics Market by Product Segment in France: 2007-2015 (Sales in US$ Million)
- Table 19: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in France for The Years 2008 &
- Table 20: Cardiovascular Disease Diagnostics Market by Product Segment in Germany: 2007-2015 (Sales in US$ Million)
- Table 21: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Germany for The Years 2008 &
- Table 22: Cardiovascular Disease Diagnostics Market by Product Segment in Italy: 2007-2015 (Sales in US$ Million)
- Table 23: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Italy for The Years 2008 &
- Table 24: Cardiovascular Disease Diagnostics Market by Product Segment in The UK: 2007-2015 (Sales in US$ Million)
- Table 25: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in The UK for The Years 2008 &
- Table 26: Cardiovascular Disease Diagnostics Market by Product Segment in Spain: 2007-2015 (Sales in US$ Million)
- Table 27: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Spain for The Years 2008 &
- Table 28: Cardiovascular Disease Diagnostics Market by Product Segment in Russia: 2007-2015 (Sales in US$ Million)
- Table 29: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Russia for The Years 2008 &
- Table 30: Cardiovascular Disease Diagnostics Market by Product Segment in Rest of Europe: 2007-2015 (Sales in US$ Million)
- Table 31: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Rest of Europe for The Years 2008 &
- Table 32: Cardiovascular Disease Diagnostics Market by Product Segment in Asia-Pacific: 2007-2015 (Sales in US$ Million)
- Table 33: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Asia-Pacific for The Years 2008 &
- Table 34: Cardiovascular Disease Diagnostics Market by Product Segment in Middle East: 2007-2015 (Sales in US$ Million)
- Table 35: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Middle East for The Years 2008 &
- Table 36: Cardiovascular Disease Diagnostics Market by Product Segment in Latin America: 2007-2015 (Sales in US$ Million)
- Table 37: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Latin America for The Years 2008 &
Companies Profiled

Pharmaceutical Market Research

Cardiovascular Disease Diagnostics

Cardiovascular Disease Diagnostics

Contents

Related products